Cargando…

Is serum PSA a predictor of male hypogonadism?

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065319/ https://www.ncbi.nlm.nih.gov/pubmed/33826838 http://dx.doi.org/10.20945/2359-3997000000356

Ejemplares similares

Is serum PSA a predictor of male hypogonadism? Testing the hypothesis
por: Amadi, Collins, et al.
Publicado: (2021)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010)

Male hypogonadism: Symptoms and treatment
por: Kumar, Peeyush, et al.
Publicado: (2010)

Hypogonadism in male cancer patients
por: Burney, Basil O., et al.
Publicado: (2012)

Substance Abuse and Male Hypogonadism
por: Duca, Ylenia, et al.
Publicado: (2019)

Editorial: Aging and male hypogonadism
por: Xia, Kai, et al.
Publicado: (2023)

Serum testosterone levels in male hypogonadism: Why and when to check—A review
por: Livingston, Mark, et al.
Publicado: (2017)

AB70. Controversies in male hypogonadism
por: Khera, Mohit
Publicado: (2014)

Approaches to male hypogonadism in primary care
por: Lawrence, Kristi L., et al.
Publicado: (2017)

Metabolic Disorders and Male Hypogonadotropic Hypogonadism
por: Pivonello, Rosario, et al.
Publicado: (2019)

Male Hypogonadism and Disorders of Sex Development
por: Grinspon, Romina P., et al.
Publicado: (2020)

Effect of exogenous glucocorticoids on male hypogonadism
por: Mohammed, Adel Gassab, et al.
Publicado: (2020)

Androgen Treatment in Adolescent Males With Hypogonadism
por: Rey, Rodolfo A., et al.
Publicado: (2020)

Biomarkers of male hypogonadism in childhood and adolescence
por: Rey, Rodolfo A.
Publicado: (2020)

FRI433 Hypogonadism In Males With Adrenoleukodystrophy
por: Alcantara, Jonanlis Ramirez, et al.
Publicado: (2023)

Bilateral male breast cancer with male potential hypogonadism
por: Hirose, Yukiko, et al.
Publicado: (2007)

Male hypogonadism in a patient with Cogan syndrome
por: Radman, Maja, et al.
Publicado: (2008)

Anabolic steroid-induced hypogonadism: a challenge for clinicians
por: Park, Hyun Jun
Publicado: (2018)

Fasting times in serum PSA assay
por: Xu, Xiang, et al.
Publicado: (2014)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
por: Chang, Tsung-Hsin, et al.
Publicado: (2020)

The Relationship between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy
por: Duran, Mesut Berkan, et al.
Publicado: (2020)

Editorial Comment from Dr Kobayashi to A case of hypogonadotropic hypogonadism due to hypophysitisdiscovered by secondary male infertility
por: Kobayashi, Hideyuki
Publicado: (2022)

Diagnosis of Male Central Hypogonadism During Childhood
por: Grinspon, Romina P, et al.
Publicado: (2021)

Metabolic patterns in insulin-resistant male hypogonadism
por: Gevi, Federica, et al.
Publicado: (2018)

Metabolic patterns in insulin-sensitive male hypogonadism
por: Fanelli, Giuseppina, et al.
Publicado: (2018)

LPCN 1144 Resolves NAFLD in Hypogonadal Males
por: Albhaisi, Somaya, et al.
Publicado: (2020)

Animal Models of Diabetes-Related Male Hypogonadism
por: Dimakopoulou, Anastasia, et al.
Publicado: (2019)

Treatment of congenital hypogonadotropic hypogonadism in male patients
por: Lee, Hae Sang, et al.
Publicado: (2022)

Plasma metabolomics in male primary and functional hypogonadism
por: Grande, Giuseppe, et al.
Publicado: (2023)

Disorders of Sex Development and Hypogonadism: Genetics, Mechanism, and Therapies
por: Guerra-Junior, Gil, et al.
Publicado: (2012)

Hypogonadotropic Hypogonadism in Diabesity: Pathogenic Factors and Therapeutic Implications
por: Dandona, Paresh, et al.
Publicado: (2022)

Male Idiopathic Hypogonadotropic Hypogonadism: Serum Insulin-like Growth Factor-1 and Oestradiol Levels
por: Salehisedeh, Nastaran, et al.
Publicado: (2022)

Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels?
por: Lee, Jaegeun, et al.
Publicado: (2021)

The role of PSA density in the MRI pathway for prostate cancer diagnostics
por: Cash, Hannes, et al.
Publicado: (2022)

Establishment of reference intervals for serum [−2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men
por: Wu, Zhi-Yu, et al.
Publicado: (2019)

Re: Fasting times in serum PSA assay
por: Lau, Cheryl K, et al.
Publicado: (2014)

Can Low SHBG Serum Concentration Be A Good Early Marker Of Male Hypogonadism In Metabolic Syndrome?
por: Jarecki, Piotr, et al.
Publicado: (2019)

Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism
por: Kim, Se Hwa
Publicado: (2014)

Efficacy and Outcome Predictors of Gonadotropin Treatment for Male Congenital Hypogonadotropic Hypogonadism: A Retrospective Study of 223 Patients
por: Liu, Zhaoxiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bjoo646d3s6ep0g1mng4u0dra5